1. Home
  2. KLTO vs CARV Comparison

KLTO vs CARV Comparison

Compare KLTO & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • CARV
  • Stock Information
  • Founded
  • KLTO 2019
  • CARV 1948
  • Country
  • KLTO United States
  • CARV United States
  • Employees
  • KLTO N/A
  • CARV N/A
  • Industry
  • KLTO
  • CARV Savings Institutions
  • Sector
  • KLTO
  • CARV Finance
  • Exchange
  • KLTO NYSE
  • CARV Nasdaq
  • Market Cap
  • KLTO 5.9M
  • CARV 7.3M
  • IPO Year
  • KLTO N/A
  • CARV 1994
  • Fundamental
  • Price
  • KLTO $1.13
  • CARV $1.80
  • Analyst Decision
  • KLTO
  • CARV
  • Analyst Count
  • KLTO 0
  • CARV 0
  • Target Price
  • KLTO N/A
  • CARV N/A
  • AVG Volume (30 Days)
  • KLTO 92.0M
  • CARV 32.4K
  • Earning Date
  • KLTO 08-15-2025
  • CARV 08-13-2025
  • Dividend Yield
  • KLTO N/A
  • CARV N/A
  • EPS Growth
  • KLTO N/A
  • CARV N/A
  • EPS
  • KLTO N/A
  • CARV N/A
  • Revenue
  • KLTO N/A
  • CARV $21,046,000.00
  • Revenue This Year
  • KLTO N/A
  • CARV N/A
  • Revenue Next Year
  • KLTO N/A
  • CARV N/A
  • P/E Ratio
  • KLTO N/A
  • CARV N/A
  • Revenue Growth
  • KLTO N/A
  • CARV N/A
  • 52 Week Low
  • KLTO $0.11
  • CARV $1.30
  • 52 Week High
  • KLTO $3.91
  • CARV $2.20
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • CARV 59.25
  • Support Level
  • KLTO N/A
  • CARV $1.60
  • Resistance Level
  • KLTO N/A
  • CARV $1.83
  • Average True Range (ATR)
  • KLTO 0.00
  • CARV 0.15
  • MACD
  • KLTO 0.00
  • CARV 0.00
  • Stochastic Oscillator
  • KLTO 0.00
  • CARV 73.53

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: